CONCORDBIO: Strong revenue growth and stable profits, with a one-time charge for regulatory changes

About this update from Concord Biotech Ltd.

Revenue and net profit grew year-over-year for both standalone and consolidated results, with a one-time exceptional charge for new Labour Codes. A new Company Secretary was appointed, and no audit qualifications or loan defaults were reported.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Concord Biotech Ltd.